Trump’s New Pharma Tariff Plan Threatens India’s $9.7 Billion Generic Drug Exports to US
In a new tariff policy, US President Donald Trump has announced a two-year grace period for foreign pharmaceutical companies to set up shop in the US before imposing steep import duties on generic medicines.Imports of generic drugs will be exempt from tariffs for two years beginning August 1, 2026, as per the policy. Trump announced […]








